FACT Capital’s SkinHealth Systems SKIN Stock Holding History

FACT Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265,716	Closed	-$2.42M	–	15
2022 Q4	$2.42M	Buy	+265,716	New	+$2.87M	1.41%	11

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FACT Capital's SKIN Position: Q1 2023 in Review

FACT Capital sold out of SkinHealth Systems (SKIN) in Q1 2023, closing a stake of 265,716 shares — an estimated $2.42M sold.

FACT Capital first reported a position in SKIN in Q4 2022 and held it in 1 quarter. The position peaked at $2.42M in Q4 2022. 158 funds tracked by Wall St. Rank hold SKIN as of Q1 2023.

FACT Capital reported no remaining SkinHealth Systems position as of Q1 2023 after selling out during the quarter.
FACT Capital sold 265,716 SkinHealth Systems shares in Q1 2023, an estimated $2.42M.
FACT Capital first reported a position in SkinHealth Systems in Q4 2022 and held it in 1 quarter.
FACT Capital's SkinHealth Systems position peaked at $2.42M in Q4 2022.
158 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2023.

Based on FACT Capital's 13F filing for Q1 2023, filed 15 May 2023.